The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2739641
WO Application Number:
US2012049357
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12746445.1
WO Publication Number:
WO2013019964
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:
Dates
Filing date:
02/08/2012
Grant date:
07/06/2017
EP Publication Date:
11/06/2014
WO Publication Date:
07/02/2013
Claims Translations Received Date:
Claims Translation B1 Received Date:
23/08/2017
Claims Translation B2 Received Date:
11/06/2020
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/09/2024
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
07/06/2017
EP B1 Publication Date:
07/06/2017
EP B2 Publication Date:
15/04/2020
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
01/08/2032
Lapsed By Expiration Date:
Patent Validated Date:
24/06/2020
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
17/06/2021
Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome
Chuo-ku, Osaka-shi, Osaka, Japan (JP)
European patents granted in amended form for the Netherlands in which an amended translation was filed ex Article 52 par. 6 of the NL Patent Law 1995
4
Bulletin Heading:
EP4
Journal edition number:
16/20
Publication date:
15/04/2020
Description:
European patents granted in amended form for the Netherlands
5
Bulletin Heading:
MED
Journal edition number:
16/20
Publication date:
15/04/2020
Description:
Other communications
6
Bulletin Heading:
VB1
Journal edition number:
16/18
Publication date:
11/04/2018
Description:
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention
7
Bulletin Heading:
EP3
Journal edition number:
36/17
Publication date:
06/09/2017
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
8
Bulletin Heading:
EP2
Journal edition number:
23/17
Publication date:
07/06/2017
Description:
European patents granted for the Netherlands
European Patent Bulletin
1
Issue number:
202016
Publication date:
15/04/2020
Description:
Patent maintained (B2 publication)
2
Issue number:
201815
Publication date:
11/04/2018
Description:
Opposition procedure started
3
Issue number:
201723
Publication date:
07/06/2017
Description:
Grant (B1)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC202101203A
Date Registered:
17/06/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Baker & McKenzie Amsterdam N.V.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome
Chuo-ku, Osaka-shi, Osaka, Japan (JP)